Vaxcyte, Inc.
US ˙ NasdaqGS ˙ US92243G1085

SecurityPCVX / Vaxcyte, Inc.
InstitutionUbs Asset Management Americas Inc
Latest Disclosed Ownership410,605 shares
Latest Disclosed Value $ 23,860,256
Ubs Asset Management Americas Inc reports 5.55% increase in ownership of PCVX / Vaxcyte, Inc.

On May 13, 2026 - Ubs Asset Management Americas Inc filed a 13F-HR form disclosing ownership of 410,605 shares of Vaxcyte, Inc. (US:PCVX) valued at $23,860,257 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 389,010 shares of Vaxcyte, Inc.. This represents a change in shares of 5.55% during the quarter. The current value of the position is $19,446,253 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F VAXCYTE COM 92243G108 410,605 21,595 5.55 23,860 32.94 0.0007
2026-02-13 2025-12-31 13F VAXCYTE COM 92243G108 389,010 -9,134 -2.29 17,949 25.15 0.0038
2025-11-14 2025-09-30 13F VAXCYTE COM 92243G108 398,144 -156,864 -28.26 14,341 -20.52 0.0031
2025-08-14 2025-06-30 13F VAXCYTE COM 92243G108 555,008 41,010 7.98 18,043 -7.03 0.0037
2025-05-19 2025-03-31 13F VAXCYTE COM 92243G108 513,998 41,034 8.68 19,409 -49.87 0.0050
2025-02-14 2024-12-31 13F VAXCYTE COM 92243G108 472,964 64,690 15.84 38,717 -17.01 0.0090
2024-11-14 2024-09-30 13F VAXCYTE COM 92243G108 408,274 112,512 38.04 46,653 108.91 0.0120
2024-08-14 2024-06-30 13F VAXCYTE COM 92243G108 295,762 187,750 173.82 22,333 202.68 0.0064
2024-05-15 2024-03-31 13F VAXCYTE EQUITY US CM 92243G108 108,012 26,539 32.57 7,378 44.21 0.0026
2024-02-14 2023-12-31 13F VAXCYTE EQUITY US CM 92243G108 81,473 6,975 9.36 5,117 34.74 0.0020
2023-11-13 2023-09-30 13F VAXCYTE EQUITY US CM 92243G108 74,498 18,467 32.96 3,798 80.81 0.0017
2023-08-11 2023-06-30 13F VAXCYTE EQUITY US CM 92243G108 56,031 0 0.00 2,100 0.00 0.0010
2023-05-15 2023-03-31 13F VAXCYTE EQUITY US CM 92243G108 56,031 4,350 8.42 2,100 -15.25 0.0010
2023-02-14 2022-12-31 13F VAXCYTE EQUITY US CM 92243G108 51,681 17,053 49.25 2,478 198.19 0.0013
2022-11-14 2022-09-30 13F VAXCYTE EQUITY US CM 92243G108 34,628 24,296 235.15 831 270.98 0.0005
2022-08-12 2022-06-30 13F VAXCYTE EQUITY US CM 92243G108 10,332 10,332 225 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.